| Drug General Information |
| Drug ID |
D02FCQ
|
| Drug Name |
Protokylol Hydrochloride
|
| Synonyms |
Ventaire
|
| Drug Type |
Small molecular drug
|
| Indication |
Bronchodilator [ICD9: 493; ICD10:J45]
|
Approved |
[1]
|
|---|
| Company |
Sanofi Aventis Us Llc
|
| Structure |
|
Download
2D MOL
|
| Formula |
C18H22ClNO5
|
| PubChem Compound ID |
|
| Target and Pathway |
| Target(s) |
Beta-1 adrenergic receptor |
Target Info |
Modulator |
|
|---|
|
KEGG Pathway
|
Calcium signaling pathway
|
|
cGMP-PKG signaling pathway
|
|
cAMP signaling pathway
|
|
Neuroactive ligand-receptor interaction
|
|
Endocytosis
|
|
Adrenergic signaling in cardiomyocytes
|
|
Gap junction
|
|
Salivary secretion
|
|
Dilated cardiomyopathy
|
|
PANTHER Pathway
|
Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway
|
|
Beta1 adrenergic receptor signaling pathway
|
|
PathWhiz Pathway
|
Muscle/Heart Contraction
|
|
Reactome
|
Adrenoceptors
|
|
G alpha (s) signalling events
|
|
WikiPathways
|
Monoamine GPCRs
|
|
Calcium Regulation in the Cardiac Cell
|
|
GPCRs, Class A Rhodopsin-like
|
|
Endothelin Pathways
|
|
GPCR ligand binding
|
|
GPCR downstream signaling
|
| References |
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
|---|
